Voglimark M 500mg/0.2mg Tablet SR
Marketer
Unimarck Healthcare Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.2mg)
Overview Voglimark M 500mg/0.2mg Tablet SR
Voglimark M 500mg/0.2mg extended-release tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Administer Voglimark M with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-managed blood sugar, as discontinuation without medical supervision risks elevated glucose levels and complications such as kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Potential side effects, such as nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin reactions, are generally transient and self-limiting. Persistent or concerning side effects warrant medical consultation; your doctor can offer management strategies. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Voglimark M 500mg/0.2mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Voglimark M 500mg/0.2mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Voglimark M 500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Voglimark M 500mg/0.2mg Tablet SR. Ingest the tablet whole; do not break, crush, or chew it. Administer this medication with a meal.
Common Side effects of Voglimark M 500mg/0.2mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Voglimark M 500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Voglimark M 500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
How Voglimark M 500mg/0.2mg Tablet SR works:
Voglimark M 500mg/0.2mg extended-release tablets contain a dual-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglimark M 500mg/0.2mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The extended-release Voglimark M 500mg/0.2mg tablet may pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Voglimark M 500mg/0.2mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglimark M 500mg/0.2mg Tablet SR. Nevertheless, patients using this medication concurrently with other antidiabetic medications, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar (hypoglycemia).
KidneyCAUTION
Patients with impaired kidney function should use Voglimark M 500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is necessary. Voglimark M 500mg/0.2mg Tablet SR is contraindicated in patients with severely compromised kidney function. Regular monitoring of renal parameters is recommended during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Voglimark M 500mg/0.2mg sustained-release tablets in individuals with hepatic impairment. Seek medical advice.
What if you forget to take Voglimark M 500mg/0.2mg Tablet SR :
Should you forget a dose of Voglimark M 500mg/0.2mg Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglimark M 500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently